You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Beyond Blame: Development of an online media literacy curriculum for violence prevention
SBC: KLEIN BUENDEL, INC. Topic: CDCThe Centers for Disease Control has determined that “youth violence is a serious public health problem that can have a long-term impact on health and well-being,” disproportionately impacting communities of color.” Violence prevention efforts, including education programs, are recommended to combat the negative impacts of violence. A number of factors exist that may increase or decrease the ...
SBIR Phase I 2023 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Live spike sorting for multichannel and high-channel recordings
SBC: POPNEURON LLC Topic: 106Project Summary: The goal of this project is to create two prototypes of a novel live spike sorting system which can be used by investigators to spike sort streams of neural data recorded by multi-channel, high channel and ultra-high channel probes. In most in-vivo extracellular recording conditions, an electrode can pick up neural spikes from several nearby neurons resulting in so-called “multi ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Developing an integrated pipeline for routine generation of orthogonal GPCR-targeting nanobodies
SBC: VITAN-BIOTECH LLC Topic: 300Project SummaryA broad range of neurological indications, including schizophrenia, pain, Parkinson's and Alzheimer's diseases, and autism have been linked to G-protein coupled receptor proteins (GPCRs), making them attractive targets for therapy. Understanding GPCR dysfunction is essential for effective therapeutic development. However, deciphering the functions of GPCRs remains a daunting task in ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Commercialization Readiness for Nerve Tape: a nerve repair coaptation aid
SBC: BIOCIRCUIT TECHNOLOGIES INC Topic: NINDSProject Summary This SBIR Commercialization Readiness Pilot project will prepare and achieve the commercial launch of Bio- Circuit Technologies’ Nerve Tape® device for sutureless nerve repair. Nerve injuries are common and result in paralysis, sensory loss, and chronic pain. In current repair techniques, the ends of a cut nerve are microsutured back together under high magnification by a specia ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients
SBC: Allander Biotechnologies Topic: NIDCRSummary Oral mucositis, a severe oral ulceration, is a common toxic effect of radio- or chemoradio-therapy (RT or CRT) and a limiting factor to using the optimal dose of radiation for effective cancer treatment. Intensity modulated RT (IMRT) and stereotactic Body RT (SBRT) spare more normal tissues and lessen chronic side effects, but not oral mucosa in head and neck cancer patients. To date, Pali ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Advanced Pediatric Airway Trainer for Enhanced Clinical Education in Pediatric Critical Care
SBC: TDA RESEARCH, INC. Topic: NICHDProject Summary/Abstract Clinical training aids such as surgical mannequins and procedural trainers are important tools for teaching proper technique to physicians and first responders. However, the majority of these training tools were developed for adult anatomies. Pediatric patients are often more challenging to treat, but few resources exist for advanced simulation in pediatric critical care e ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
The Point Powered: A Robust Actuated Prosthetic Finger for Partial Hand Amputation
SBC: POINT DESIGNS, LLC Topic: NIBIBABSTRACT Approximately 600,000 people live with partial hand limb loss (PHLL) in the United States, with an estimated 14,500 new cases occurring each year. Despite the advances in miniaturized electronics and motors, there has been very little advancement in mechatronic prosthetic digits for this underserved patient population. In fact, to date, there is only one myoelectric prosthetic option for ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
ADEPT-STAR therapy for high risk neuroblastoma
SBC: EXPRESSION THERAPEUTICS, LLC Topic: 100PROJECT SUMMARY Cancer remains a primary health concern despite significant advancements in treatment. In the past decade, cell and gene (CandG) therapies along with immuno-oncology (I-O) therapies have transformed treatment expectations by extending cancer free survival and complete remissions. Despite these remarkable successes, they are limited to a subset of cancers and many significant challe ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel targeted CAR-T multiple myeloma therapy
SBC: Novab, Inc. Topic: 102PROJECT SUMMARY Multiple myeloma (MM), a malignancy of plasma cells (PCs), is responsible for over 12,500 deaths in the US and over 117,000 deaths worldwide annually. Over 91,000 individuals in the US and over 300,000 worldwide currently live with MM. In spite of major therapeutic advances in the past two decades, MM remains incurable and most MM patients succumb to the underlying malignancy. Rece ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Precision MRI with a Novel Protein Contrast Agent for Early Detection and Staging of Lung Fibrosis
SBC: INLIGHTA BIOSCIENCES L.L.C. Topic: NHLBISummary Lung diseases, such as interstitial lung diseases including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and acute viral infection are major leading causes of death worldwide. The recent increase due to air pollution, tobacco smoking is and use of E-cigarettes has grown rapidly in the US contributing to a sharp increase in chronic lung diseases. IPF is ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health